291 related articles for article (PubMed ID: 27528237)
1. Laurence Klotz on the Controversy Surrounding Screening for Prostate Cancer.
Klotz L
Oncology (Williston Park); 2016 Aug; 30(8):694, 764. PubMed ID: 27528237
[No Abstract] [Full Text] [Related]
2. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?
Jackson BR
Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565
[No Abstract] [Full Text] [Related]
3. Alternative prostate cancer screening strategies.
Labrecque M; Aprikian A
Ann Intern Med; 2013 May; 158(10):778. PubMed ID: 23689773
[No Abstract] [Full Text] [Related]
4. Alternative prostate cancer screening strategies--in response.
Gulati R; Etzioni R
Ann Intern Med; 2013 May; 158(10):778-9. PubMed ID: 23689774
[No Abstract] [Full Text] [Related]
5. Probability, uncertainty, and prostate cancer.
Concato J
Ann Intern Med; 2013 Feb; 158(3):211-212. PubMed ID: 23381041
[No Abstract] [Full Text] [Related]
6. Early detection of prostate cancer.
Taneja SS
Urol Clin North Am; 2014 May; 41(2):xi-xii. PubMed ID: 24725495
[No Abstract] [Full Text] [Related]
7. Words of wisdom: Re: Comparative effectiveness of alternative prostate-specific antigen-based prostate cancer screening strategies: model estimates of potential benefits and harms.
Vickers A
Eur Urol; 2013 Oct; 64(4):682-3. PubMed ID: 23998500
[No Abstract] [Full Text] [Related]
8. Early detection of prostate cancer: can we have our cake and eat it too?
Masterson TA; Cary C; Cheng L
Expert Rev Anticancer Ther; 2016; 16(3):247-9. PubMed ID: 26760708
[No Abstract] [Full Text] [Related]
9. Prostate cancer screening.
Eastham J
Investig Clin Urol; 2017 Jul; 58(4):217-219. PubMed ID: 28681029
[No Abstract] [Full Text] [Related]
10. Prostate cancer: Numeracy and understanding of risk reduction of PSA screening.
Subramanian V; Kattan MW
Nat Rev Urol; 2018 Apr; 15(4):208-209. PubMed ID: 29460924
[No Abstract] [Full Text] [Related]
11. The Roles of Providers and Patients in the Overuse of Prostate-Specific Antigen Screening in the United States.
Guo F; He D
Ann Intern Med; 2015 Oct; 163(8):650-1. PubMed ID: 26502132
[No Abstract] [Full Text] [Related]
12. Summaries for patients. Screening smarter, not harder, for prostate cancer.
Ann Intern Med; 2013 Feb; 158(3):I-30. PubMed ID: 23381056
[No Abstract] [Full Text] [Related]
13. [Does a low PSA at 60 years old exclude the risk of developing prostate carcinoma?].
Zürcher S
Rev Med Suisse; 2014 Jun; 10(434):1316. PubMed ID: 25073308
[No Abstract] [Full Text] [Related]
14. Prostate Cancer Screening and the Associated Controversy.
Tabayoyong W; Abouassaly R
Surg Clin North Am; 2015 Oct; 95(5):1023-39. PubMed ID: 26315521
[TBL] [Abstract][Full Text] [Related]
15. The need for active surveillance for low risk prostate cancer.
Drost FH; Roobol MJ
Expert Rev Anticancer Ther; 2017 Jun; 17(6):487-489. PubMed ID: 28406334
[No Abstract] [Full Text] [Related]
16. Correlation between stage shift and differences in mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC).
Bokhorst LP; Zappa M; Carlsson SV; Kwiatkowski M; Denis L; Paez A; Hugosson J; Moss S; Auvinen A; Roobol MJ
BJU Int; 2016 Nov; 118(5):677-680. PubMed ID: 27104278
[TBL] [Abstract][Full Text] [Related]
17. [Screening for prostate cancer using prostate-specific antigen (PSA) : A commentary on a systematic review and meta-analysis].
Borkowetz A
Urologe A; 2019 Aug; 58(8):925-928. PubMed ID: 31240375
[No Abstract] [Full Text] [Related]
18. [Current aspects of prostate cancer screening].
Jalón Monzón A; Escaf Barmadah S; Viña Alonso LM; Jalón Monzón M
Semergen; 2017; 43(5):387-393. PubMed ID: 27562331
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer screening "reloaded".
Gomella LG
Can J Urol; 2010 Apr; 17(2):5057. PubMed ID: 20398441
[No Abstract] [Full Text] [Related]
20. Screening for prostate cancer remains controversial.
Neal DE; Donovan JL; Martin RM; Hamdy FC
Lancet; 2009 Oct; 374(9700):1482-3. PubMed ID: 19664817
[No Abstract] [Full Text] [Related]
[Next] [New Search]
